Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Name: Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
SKU: 4223
Price: 30.00 USD
Availability: InStock

$30.00

ORIGINAL RESEARCH

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

By Andrew C. Leon

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 42 No. 2 Articles Tags: andrew-c-leon, attrition, cure-model, multiplicity, onset-of-action, original-research, randomized-controlled-clinical-trials

Description

Description

ORIGINAL RESEARCH

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

By Andrew C. Leon

PB-42-2-2009-Leon

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Description

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention

John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment

A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder

Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action

Description

Related products

Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)

The Addition of Amphetamine to Potentially Sedating Medication Regimens: An Exploratory Investigation of the Impact upon Reaction Time and Sustained Attention

John P. Houston – Early Symptom Change Prediction of Remission in Depression Treatment

A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder